Effect of spherical aberration on visual acuity and depth of focus in pseudophakic eyes.

J Cataract Refract Surg

From the Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas.

Published: January 2024

Purpose: To assess the performance of 4 intraocular lenses (IOLs) in various spherical aberration (SA) conditions, using the VAO adaptive optics simulator.

Setting: Cullen Eye Institute, Baylor College of Medicine, Houston, Texas.

Design: Prospective case series.

Methods: Distance-corrected visual acuities at distance (CDVA), intermediate (DCIVA), and near (DCNVA) were measured in 42 dilated pseudophakic eyes at baseline and with ocular SA ranging from -0.4 to +0.4 μm in increments of 0.2 μm (6.0-mm pupil). 4 IOL types were assessed: monofocal IOLs with zero-SA, enhanced-monofocal, extended depth-of-focus (EDOF), and continuous range-of-vision.

Results: Compared with SA = 0 μm, significant changes (all P < .05) were: (1) zero-SA monofocal IOLs' DCNVA at high contrast improved by 0.13 logMAR with SA = -0.4 μm and worsened by 0.09 and 0.10 logMAR with SA = +0.2 and +0.4 μm, respectively. DCNVA at low contrast worsened by 0.09 logMAR with SA = +0.4 μm; and (2) with SA = -0.4 μm, the enhanced monofocal IOL lost 0.06 logMAR of CDVA at high contrast and gained 0.09 logMAR of DCNVA at low contrast. There were no significant changes from SA = 0 μm for EDOF and continuous range-of-vision IOLs.

Conclusions: Zero-SA and EDOF IOLs were the most and least sensitive to SA modulation, respectively. In perfect optical systems where all the optical elements are aligned, induction of targeted amounts of negative SA improved the depth of focus of some IOL types. No benefit was found with positive SA.

Download full-text PDF

Source
http://dx.doi.org/10.1097/j.jcrs.0000000000001314DOI Listing

Publication Analysis

Top Keywords

+04 μm
12
spherical aberration
8
depth focus
8
pseudophakic eyes
8
μm
8
iol types
8
edof continuous
8
high contrast
8
-04 μm
8
worsened 009
8

Similar Publications

Antithrombotic therapy and the risk of pocket hematoma after subcutaneous implantable cardioverter-defibrillator implantation.

J Interv Card Electrophysiol

January 2025

Heart Center, Department of Cardiology, Amsterdam Cardiovascular Sciences Heart Failure & Arrhythmias, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands.

Background: Little data exists regarding the optimal antithrombotic strategy during S-ICD implantation to prevent pocket hematomas. This study explores the association between perioperative antithrombotic management and the occurrence of pocket hematoma following S-ICD implantation.

Methods: All patients who underwent de novo S-ICD implantation between February 2009 and January 2023 at Amsterdam UMC were included.

View Article and Find Full Text PDF

Facile Preparation of Polymerizable Deep Eutectic Solvents Under Mild Conditions for Multisensory Ionic Skins.

Small

December 2024

College of Polymer Science and Engineering, State Key Laboratory of Polymer Materials Engineering, Sichuan University, Chengdu, 610065, China.

Polymerizable deep eutectic solvents (PDESs) have emerged as promising building blocks for next-generation eutectic gels, offering new opportunities for the development of advanced electronic devices. Traditional PDES fabrication typically involves heating and extended processing time. In this study, a facile method where a solid-solid mixture of lithium bis(trifluoromethane) sulfonimide (LiTFSI) and acrylamide (AAm) rapidly forms a PDES at room temperature, significantly simplifying the ionogel preparation is presented.

View Article and Find Full Text PDF
Article Synopsis
  • Metabolic syndrome (MetS) is a significant global cardiovascular risk, and this study examined how the age at menarche (AAM) impacts MetS and its components across different generations of women.
  • The research involved 5,500 women from the Tehran Lipid and Glucose Study, categorizing them by birth cohorts and AAM, and utilized logistic regression to analyze the relationship between AAM and MetS prevalence.
  • Results indicated that early menarche (≤ 11 years) increases the risk of MetS, particularly in older generations, while late menarche (≥ 16 years) appears protective against certain metabolic issues, highlighting generational differences in AAM's impact on metabolic health.
View Article and Find Full Text PDF

Background: Iron deficiency is prevalent among heart failure patients and is associated with worse clinical outcomes, including decreased quality of life and functional capacity. This condition often results in a higher incidence of hospitalization and mortality. Iron supplementation, particularly with intravenous ferric carboxymaltose (FCM), has shown potential benefits as an adjunct therapy in heart failure management.

View Article and Find Full Text PDF

Background: Women are often neglected in cardiovascular health prevention. Age at menarche (AAM) has been linked to cardiovascular (CVD) disease in women and is potentially identified as one of the significant CVD risk factor. However, there is still limited comprehensive evidence addressing this issue.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!